Denver, CO 的 前列腺癌 臨床試驗
19 項針對 前列腺癌 的研究正在 Denver（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
招募中1/2 期
- Rocky Mountain Cancer Center, Denver
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
招募中3 期
- Kaiser Permanente-Franklin, Denver
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
招募中1 期
- Sarah Cannon Research Institute at HealthOne, Denver
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
招募中觀察性研究歡迎健康志工
- AdventHealth Porter, Denver
Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
招募中1/2 期
- Sarah Cannon Research Institute 1, Denver
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
招募中3 期
- AdventHealth Medical Group Urology of Denver, Denver
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
招募中2/3 期
- Rocky Mountain Cancer Centers, Denver
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
招募中3 期
- Rocky Mountain Cancer Centers, Denver
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
招募中3 期
- Rocky Mountain Cancer Centers, Denver
A Study of GSK5458514 Administered Alone or In Combination With Other Anti-Cancer Agents in Participants With Prostate Cancer
招募中1/2 期
- GSK Investigational Site, Denver
Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer
招募中1 期
- Rocky Mountain Cancer Centers, Denver
- United States Oncology Regulatory Affairs Corporate Office, Denver
- US Oncology Research Investigational Products Center, Denver
The Vanguard Study: Testing a New Way to Screen for Cancer
招募中歡迎健康志工
- Kaiser Permanente-Franklin, Denver
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
招募中1 期
- Sarah Cannon Research Institute - Denver DDU, Denver
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
招募中3 期
- UCHealth - Cherry Creek, Denver
Pragmatic Trial of Metformin for Glucose Intolerance or Increased BMI in Prostate Cancer Patients
招募中早期第 1 期
- UCHealth-Metro Denver, Denver
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
招募中1/2 期
- Sarah Cannon Research Institute, Denver
Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
招募中2 期
- Porter Adventist Hospital, Denver
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中觀察性研究
- Massive Bio SYNERGY-AI site, Denver
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
招募中3 期
- Porter Adventist Hospital, Denver
其他城市的 前列腺癌 試驗
- New York City, NY103 項研究
- Houston, TX76 項研究
- Los Angeles, CA61 項研究
- Boston, MA59 項研究
- St. Louis, MO46 項研究
- Chicago, IL45 項研究
- San Francisco, CA45 項研究
- Philadelphia, PA44 項研究
- Baltimore, MD43 項研究
- Nashville, TN42 項研究
- Seattle, WA42 項研究
- Washington, DC38 項研究
Denver 的其他研究
- 轉移性癌症29 項研究
- 乳癌28 項研究
- 多發性骨髓瘤27 項研究
- 非小細胞肺癌27 項研究
- 大腸直腸癌23 項研究
- 黑色素瘤19 項研究
- 癌症（所有類型）18 項研究
- 卵巢癌16 項研究
- 肺癌16 項研究
- 子宮內膜癌15 項研究
- 非霍奇金淋巴瘤14 項研究
- 胰臟癌13 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月5日。各研究自行設定資格標準；由研究團隊決定參與者資格。